Justin C. Frankel, P.C., represented a client with Chronic Lymphocytic Leukemia whose long-term disability benefits ...

After adjustment for other factors, a CFS of 3 or higher and relapsed/refractory disease were the only independent predictors of early zanubrutinib discontinuation.

In November 2025, Nurix appointed accomplished biopharmaceutical leader Roger Dansey, M.D., to its Board of Directors, adding ...

Better treatment and earlier diagnosis mean that 7 in 10 people will survive five years or more after a cancer diagnosis.

For a long time, China has been a major exporter of cross-border medical demand. Approximately 800,000 Chinese citizens ...

-- Dr. Mobasher held several executive roles in industry, most recently CMO at BeiGene -- IFLI contributed up to $9 million to Enterome's private funding round in 2025 -- Enterome has announced a ...

Researchers analyzed the health records of more than 33,800 U.S. veterans diagnosed with non-melanoma skin cancer and found ...

The world of professional wrestling had many notable deaths in 2025, including the legendary Hulk Hogan and ‘Voice of Mid-Atlantic Wrestling’ Bob Caudle ...

Oncoscope launches the first Real-time, AI-supported Living Systematic Literature Review designed for enterprise-wide ...

Hulk Hogan isn’t actually spending much time doing anything these days… because the legendary WWE wrestler died last year.

Speakers delved into innovative strategies in skin tumor management, focusing on chemotherapies, patient risk assessment, and evolving treatment protocols.

Detailed price information for Ascentage Pharma Group Intl ADR (AAPG-Q) from The Globe and Mail including charting and trades.